Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

Abstract

Many therapeutic clinical trials have proposed using a measure of metabolic change to assess therapeutic response rather than relying on conventional anatomic measurements of changes in tumor size on CT or MRI. PET assessment of changes in 18F-FDG uptake by tumors is gaining acceptance as such a

References

Page 1

	Year	Citations
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data Clifford S. Patlak, Ronald G. Blasberg, Joseph D. Fenstermacher Journal of Cerebral Blood Flow & Metabolism EngineeringNeurophysiological BiomarkersBiomedical EngineeringCerebral Vascular RegulationBlood Flow	1983	3.6K
Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations Helen Young, R. Baum, U. Cremerius, European Journal of Cancer Positron Emission TomographySubclinical Tumour ResponseEngineeringOncologic ImagingMedical Imaging	1999	1.7K
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations Clifford S. Patlak, Ronald G. Blasberg Journal of Cerebral Blood Flow & Metabolism EngineeringNeurophysiological BiomarkersBiomedical EngineeringBlood FlowBioanalysis	1985	1.7K
THE METABOLISM OF TUMORS OTTO WARBURN, F. Dickens The American Journal of the Medical Sciences Metabolism Of TumorsMedicinePathologyCancer MetabolismMalignant Disease	1931	813
Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. Ronald Boellaard, Nanda C. Krak, Otto S. Hoekstra, PubMed	2004	653
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography Reinhard Bos Journal of Clinical Oncology	2002	537
Reproducibility of metabolic measurements in malignant tumors using FDG PET. Wolfgang Weber, Sibylle Ziegler, R. Thödtmann, PubMed	1999	394
Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. Hubert Vesselle, Rodney A. Schmidt, Jeffrey M. Pugsley, PubMed Surgical OncologyOncologic ImagingPet-mriPathologyLung Cancer Proliferation	2000	355
Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. Kotaro Higashi, Anaira C. Clavo, Richard L. Wahl PubMed PathologyCell ProliferationMeasure Proliferative ActivityDoes FdgCancer Biology	1993	313
Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction Yoshifumi Sugawara, Kenneth Zasadny, A Neuhoff, Radiology	1999	264

Page 1